These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13121073)

  • 1. Hydrodextran: preparation, and study on blood level and excretion rate.
    TRYON PF; BLOOM WL
    Proc Soc Exp Biol Med; 1953 Nov; 84(2):462-4. PubMed ID: 13121073
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrodextran in the treatment of hemorrhagic shock: with plasma volume, blood volume, protein and excretion studies.
    HARRISON JH; DURDEN WF; KELLUM AS
    Ann Surg; 1955 Nov; 142(5):824-30. PubMed ID: 13269033
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physical and chemical properties and pharmacological and toxicological study of potassium hydrodextran sulphate].
    Parés J; Drobnic L; Margarit M; Taxonera F; Sabater-Tobella J
    Therapie; 1969; 24(6):1071-87. PubMed ID: 5367185
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pharmacokinetic considerations in the use of plasma expanders.
    Klotz U; Kroemer H
    Clin Pharmacokinet; 1987 Feb; 12(2):123-35. PubMed ID: 2435442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sodium hydrodextran sulfate on experimental arteriosclerosis in spontaneously hypertensive rats].
    Tashiro Y; Sato M; Chonan Y; Wakabayashi K; Iwaki R
    Nihon Yakurigaku Zasshi; 1973 Nov; 69(6):931-45. PubMed ID: 4799522
    [No Abstract]   [Full Text] [Related]  

  • 6. Covalent linkage of carboxypeptidase G2 to soluble dextrans--II. In vivo distribution and fate of conjugates.
    Melton RG; Wiblin CN; Baskerville A; Foster RL; Sherwood RF
    Biochem Pharmacol; 1987 Jan; 36(1):113-21. PubMed ID: 2432899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion characteristics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate.
    Takakura Y; Kato A; Hashida M; Honda K; Arimoto A; Satomura K; Sezaki H
    J Pharmacobiodyn; 1985 May; 8(5):357-64. PubMed ID: 2413196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the kinetics and renal excretion of low and high molecular weight dextrans in preterm babies, newborns and young infants.
    Emmrich P; Baumann W; Stechele U
    Eur J Pediatr; 1977 Jul; 125(3):181-90. PubMed ID: 885145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the potential use of anionic dextrans as a plasma substitute.
    Chang RL; Crawford MP; West MD
    J Biomed Eng; 1980 Jan; 2(1):41-4. PubMed ID: 7359897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international collaborative study of dextran sulfate.
    MUSSETT MV; PERRY WL
    Bull World Health Organ; 1956; 14(4):647-56. PubMed ID: 13356141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of benzoyl dextran and its use in aqueous two-phase systems.
    Lu M; Tjerneld F; Johansson G; Albertsson PA
    Bioseparation; 1991; 2(4):247-55. PubMed ID: 1373980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of charged and uncharged dextrans from normal and injured lungs.
    Barrowcliffe MP; Zanelli GD; Ellison D; Jones JG
    J Appl Physiol (1985); 1990 Jan; 68(1):341-7. PubMed ID: 1690203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of intravenously administered dextran.
    ENGSTRAND L; ABERG B
    Lancet; 1950 Jun; 1(6615):1071-3. PubMed ID: 15422822
    [No Abstract]   [Full Text] [Related]  

  • 14. Gel permeation chromatography of dextrans in parenteral solutions: calibration procedure development and method validation.
    Karmarkar S; Garber R; Kluza J; Koberda M
    J Pharm Biomed Anal; 2006 Jun; 41(4):1260-7. PubMed ID: 16650708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo cleavage rate of a dextran-bound magnetic resonance imaging contrast agent: preparation and intravascular pharmacokinetic characteristics in the rabbit.
    Hals PA; Sontum PC; Holtz E; Klaveness J; Rongved P
    Curr Drug Deliv; 2013 Feb; 10(1):134-43. PubMed ID: 22452401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal excretion and volume of distribution of various dextrans.
    GIEBISCH G; LAUSON HD; PITTS RF
    Am J Physiol; 1954 Jul; 178(1):168-76. PubMed ID: 13180734
    [No Abstract]   [Full Text] [Related]  

  • 17. Silylation reaction of dextran: effect of experimental conditions on silylation yield, regioselectivity, and chemical stability of silylated dextrans.
    Nouvel C; Dubois P; Dellacherie E; Six JL
    Biomacromolecules; 2003; 4(5):1443-50. PubMed ID: 12959617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal excretion and molecular size distribution of dextran.
    GRONWALL A; HINT H; INGELMAN B; WALLENIUS G; WILANDER O
    Scand J Clin Lab Invest; 1952; 4(4):363-8. PubMed ID: 13048619
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of red blood cell aggregation with dextran by ultrasonic interferometry.
    Razavian SM; Guillemin MT; Guillet R; Beuzard Y; Boynard M
    Biorheology; 1991; 28(1-2):89-97. PubMed ID: 1710940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [STUDIES ON ABSORPTION AND EXCRETION OF DRUGS. I. FE-59 LABELED IRON DEXTRAN AND FE-59 LABELED IRON FUMARATE].
    IWAKI R; TAMURA Y
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():435-41. PubMed ID: 14271234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.